Related Experiment Videos
Interference of MIBG uptake by medication: a case report
L Apeldoorn1, H J Voerman, C A Hoefnagel
1Department of Internal Medicine, Ziekenhuis Amstelveen, Netherlands.
The Netherlands Journal of Medicine
|May 1, 1995
Summary
Labetalol can interfere with MIBG scans used to diagnose phaeochromocytoma, a cause of hypertension. Discontinuing labetalol and other interfering medications before the scan is advisable for accurate results.
Area of Science:
- Endocrinology
- Nuclear Medicine
- Cardiology
Background:
- Phaeochromocytoma is a rare adrenal tumor causing hypertension.
- Accurate diagnosis relies on imaging techniques like MIBG scintigraphy.
- Medications can potentially interfere with diagnostic imaging.
Observation:
- A patient with suspected phaeochromocytoma presented with severe hypertension and elevated catecholamines.
- Labetalol was administered, leading to abnormal MIBG scan findings.
- Discontinuation of labetalol normalized the MIBG scan biodistribution.
Findings:
- Labetalol can alter the biodistribution of 123I-MIBG, causing abnormal scan results.
- This interference can lead to misdiagnosis or delayed diagnosis of phaeochromocytoma.
- A list of known interfering drugs and potential interferers is provided.
Implications:
- Discontinuing interfering medications, including labetalol, is crucial before MIBG scintigraphy.
- This practice ensures the accuracy of phaeochromocytoma diagnosis.
- Guidelines for medication management prior to MIBG scans should be considered.